Who Paid My Doc
Lx9211
Research payments
$5,619,568
Through program year 2025, $5,619,568 in research payments was reported against Lx9211, across 742 payments, paid by Lexicon Pharmaceuticals, Inc..
- Paid by
- Lexicon Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,648,252 | 110 |
| 2024 | Research | $3,971,316 | 632 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Manjoo Sharma Hempstead, NY Named on 39 payments
- Leon Barkodar West Hills, CA Named on 28 payments
- Kimberly Cruz Pompano Beach, FL Named on 26 payments
- Soheil Hekmat Inglewood, CA Named on 24 payments
- James Lilly Dallas, TX Named on 24 payments
- Anand Patel Jacksonville, FL Named on 22 payments
- John Beckes National City, CA Named on 22 payments
- Thomas Marbury Orlando, FL Named on 19 payments
- Patrick Dennis New Orleans, LA Named on 17 payments
- Michael Stephens Orange Park, FL Named on 17 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.